Dawnhealth
1 known investors
Dawn Health builds white-label digital health products—such as clinical trial companions, disease management and therapy companion apps—for pharmaceutical companies using a modular, ISO 13485-certified platform. Its products incorporate AI, digital biomarkers and patient-reported outcomes across therapeutic areas including oncology, neurology, endocrinology and rare pediatric diseases, with deployments in Europe, North America and Asia.